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Abstract
Glioblastoma multiforme is a brain malignancy characterized by high heterogeneity, invasiveness, and resistance to current
therapies, attributes related to the occurrence of glioma stem cells (GSCs). Transforming growth factor β (TGFβ) promotes
self-renewal and bone morphogenetic protein (BMP) induces differentiation of GSCs. BMP7 induces the transcription factor
Snail to promote astrocytic differentiation in GSCs and suppress tumor growth in vivo. We demonstrate that Snail represses
stemness in GSCs. Snail interacts with SMAD signaling mediators, generates a positive feedback loop of BMP signaling and
transcriptionally represses the TGFB1 gene, decreasing TGFβ1 signaling activity. Exogenous TGFβ1 counteracts Snail
function in vitro, and in vivo promotes proliferation and re-expression of Nestin, conﬁrming the importance of TGFB1 gene
repression by Snail. In conclusion, novel insight highlights mechanisms whereby Snail differentially regulates the activity of
the opposing BMP and TGFβ pathways, thus promoting an astrocytic fate switch and repressing stemness in GSCs.
Introduction
Glioblastoma multiforme (GBM) is a fatal adult brain tumor
with median survival of 12–15 months [1]. GBM exhibits
heterogeneous differentiation, high invasiveness, vascular
density, and resistance to radiotherapy and chemotherapy
[2]. GBM cancer stem cells are non-responsive to current
treatments and contribute to acquired chemoresistance [3].
These glioma stem cells (GSCs) self-renew and are
responsible for tumor initiation, propagation, and relapse
after therapy [4]. GSCs resemble neural stem cells, as their
fate is controlled by environmental cues such as Notch,
Wnt, and the transforming growth factor β (TGFβ) family
[5, 6].
The 33 members of the human TGFβ family contain the
TGFβ and the bone morphogenetic protein (BMP) sub-
families [7]. These ligands bind to type II receptors
(TGFBR2, ACVR2A, ACVR2B, BMPR2, and AMHR2),
facilitating recruitment and phosphorylation of the type I
receptors, also known as activin receptor-like kinases
(ALK: ALK4/5/7 for the TGFβ and ALK1/2/3/6 for the
BMP subfamily). Hetero-tetrameric receptors signal via
non-SMAD and SMAD pathways. Type I TGFβ receptors
phosphorylate receptor-regulated (R-)SMADs, i.e.,
SMAD2/3, and BMP receptors phosphorylate SMAD1/5/8;
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activated R-SMADs form complexes with SMAD4 and
regulate transcription of genes [7]. In addition, inhibitory (I-
) SMADs (SMAD6/7) inhibit these pathways.
Mimicking their functions during normal brain devel-
opment, TGFβ members play opposing roles in the main-
tenance of GSCs in human GBM. TGFβ promotes GSC
proliferation [8] and self-renewal by inducing leukemia
inhibitory factor (LIF) [9] and Sox2 [10] expression. BMPs
direct GSC differentiation toward the astrocytic lineage and
deplete the GSC pool, acting as tumor suppressors [11–14].
GSCs are protected from paracrine BMP actions by
expressing the extracellular antagonist Gremlin [15].
Clinically, anti-TGFβ therapy in GBM offers promising
results [16].
We previously described that BMPs exert their differ-
entiation effects by inducing the transcription factor Snail
[13]. Snail promotes epithelial-to-mesenchymal transition
(EMT) in embryos or epithelial-derived tumors [17]. In
GBM, Snail promotes invasion [13, 18, 19], but mechan-
isms by which Snail impairs GSC self-renewal and pro-
motes astrocytic fate remain unknown. We have addressed
this important question and demonstrate an intriguing feed-
forward loop whereby Snail controls the activities of both
TGFβ and BMP pathways at the level of secreted ligands
and intracellular SMAD function.
Results
Snail promotes astrocytic fate and enhances the
BMP pathway
By screening a panel of patient-derived, established
(U2987MG, U2990MG, U343MG, M343MGa-Cl2.6) and
stem cell lines (U3013MG, U3024MG, U3028MG,
U3034MG), we found that U2987MG, U3013MG,
U3024MG, U3028MG, and U3034MG cultures contained
GSCs, whereas the other GBM cell models did not [13]. We
employed U2987MG cells, which exhibited more robust
and sustained responses to TGFβ1 and BMP2, BMP4, and
BMP7 signaling, compared to the other models (Supple-
mentary Figure S1, where both TGFβ1 and BMP7 induce
R-Smad phosphorylation up to 72 h after stimulation and
for other gene responses [13]). Transcriptomic analysis in
U2987MG cells stably expressing Snail (U2987MG-Snail
cells; clones F and G) versus control cells (clones A and B)
in duplicate identiﬁed 1100 differentially expressed genes.
Among the top upregulated genes in the U2987MG-Snail
cells were astrocytic differentiation markers, the inter-
mediate ﬁlament glial acidic ﬁbrilary protein (GFAP) and
the extracellular matrix glycoprotein secreted protein,
acidic, cysteine rich-like-1 (SPARCL1) (Fig. 1a, b). In order
to corroborate that Snail can induce astrocytic fate in
GBMs, we compared the differentially expressed genes in
our dataset to those differentially expressed genes in normal
mouse astrocytes versus other brain cell lineages (oligo-
dendrocyte progenitors, oligodendrocytes, neurons, cultured
astroglia) reported by Cahoy et al. [20] We chose a murine
dataset as this one contained several brain cell types and
allowed us to discriminate genes expressed in astrocytes
from those in other brain cell types. The resulting 130
common genes were plotted in a heatmap relative to the
biological samples, named according to cell clone and their
respective duplicates (bis, Fig. 1a). GBM-Snail clones
expressed very high (GFAP), intermediately high
(SPARCL1), and moderately high (GLUL, glutamate-
ammonia ligase, another astrocytic marker) levels (Fig.
1b); note the differences in the basal level of expression of
these genes (Supplementary Figure S2A).
Next, we conﬁrmed that Snail-induced astrocytic differ-
entiation coincided with loss of stem cell and multidrug
resistance gene expression, as these were previously linked
to GSC stemness and chemoresistance (Fig. 1c, d; Supple-
mentary Figure S2B). Moreover, U2987MG-Snail cells
exhibited loss of self-renewal capacity measured by limiting
dilution assay of gliomasphere formation (Fig. 1e).
Unexpectedly, among the co-expressed genes in
U2987MG-Snail and normal astrocytic cells (Fig. 1a), were
inhibitor of differentiation-4 (ID4) and N-myc downstream
regulated-1 (NDRG1), both established targets of BMP
signaling [21, 22]. Validation of expression of all four ID
family members indicated that Snail induced only ID4 (Fig.
2a, Supplementary Figure S3A). Consequently, GSCs
expressing Snail exhibited enhanced phospho-SMAD1/5
levels, without changing their total SMAD1/5 (Fig. 2b).
Systematic analysis of BMP pathway genes showed that
GSCs expressing Snail had diminished expression of three
BMP receptors (ALK2, ACVR2B, and BMPRII), whereas
ALK6 and ACVR2A did not change signiﬁcantly (Supple-
mentary Figure S3B, C). Furthermore, BMP receptor
Fig. 1 Snail promotes astrocytic fate switch and impairs self-renewal
capacity in GSCs. a Subgroup of genome-wide mRNA expression in
U2987MG-Snail (clones F and G) or U2987MG-mock cells (pcDNA3
clones A and B). A heatmap displays differentially expressed genes,
common between astrocytes (Cahoy et al. [20]) and U2987MG-Snail
clones. Upregulated (red) and downregulated (blue) genes are listed;
relevant genes are highlighted. b, c qRT-PCR analysis of mRNA
expression (n= 3–6, technical triplicate) presented as mean± SD.
Statistical comparison (one-way Anova) indicates signiﬁcant differ-
ences at: *p< 0.05, **p< 0.01, ***p< 0.001. d Nestin immunoblot
with loading control (Gapdh) in cells cultured in complete (FBS)
media for 48 h. e ELDA of U2987MG cells (A-pcDNA3, black
symbols and F-Snail, red symbols) cultured for 10 days (n= 2, tech-
nical octaplicates). The number of wells containing spheres for each
plating density is plotted. Steeper slopes indicate higher frequencies of
sphere-forming cells. A table indicates average stem cell frequency per
cell group
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expression was not strongly affected upon stable knock-
down of endogenous Snail in parental U2987MG cells
(Supplementary Figure S3D, E). Interestingly, Snail-
expressing cells exhibited lower levels of extracellular
(chordin (CHRD), chordin-like-2 (CHRDL2)) and intracel-
lular (SMAD6, SMAD7) negative regulators of BMP sig-
naling (Fig. 2c, e); on the other hand, these cells showed
high BMP4/5 mRNA levels and signiﬁcant upregulation of
secreted BMP4 protein in the tumor cell media (Fig. 2d–f).
In contrast, BMP2/7 mRNA levels did not signiﬁcantly
change (Supplementary Figure S3F). The transcription
factor GATA6 can repress BMP4 expression in colon
cancer cells [23]; accordingly, GBM cells expressing Snail
showed signiﬁcantly repressed GATA6 mRNA (Supple-
mentary Figure S3G), which can explain the dramatic
derepression of BMP4 observed in these cells (Fig. 2d–f).
The Snail-induced BMP pathway governs astrocytic
fate
In order to elucidate the role of BMP signaling in Snail-
induced astrocytic fate determination, we blocked the BMP
pathway at multiple levels. Interfering with BMPR activity
or expression, diminished GFAP, SPARCL1, and ID4
mRNA and GFAP protein levels, and decreased phospho-
SMAD1/5 levels in GSCs expressing Snail (Supplementary
Figure S4). Silencing the BMP effectors SMAD1/5 indivi-
dually or in combination (Supplementary Figure S5A)
diminished GFAP and ID4 expression (Fig. 2g, Supple-
mentary Figure S5C) and decreased the nuclear accumula-
tion of phosphorylated-SMAD1/5 (Fig. 2h). However, these
speciﬁc small interfering RNAs (siRNAs) targeting
SMAD1 and SMAD5 had no effect on GSC stem cell gene
repression by Snail (Supplementary Figure S5B). To
investigate the role of autocrine-secreted BMPs, we treated
the cells with the physiological extracellular BMP
antagonist Noggin; GFAP mRNA and protein levels and
ID4 mRNA expression and nuclear accumulation of phos-
pho-SMAD1/5 levels were diminished (Fig. 2i, j, Supple-
mentary Figure 5D). In agreement with the SMAD1/
5 silencing results, Noggin failed to revert the stem cell
gene suppression by Snail (Supplementary Figure S5E).
Snail suppresses TGFβ1 signaling
TGFβ promotes stem cell properties in glioma [24]. In order
to explore whether TGFβ pathways, in addition to BMPs,
are affected in GBM cells expressing Snail, we checked the
expression levels of TGFβ isoforms and downstream
effectors in our microarray (Supplementary Figure S6A);
this gave a ﬁrst indication that TGFβ1 ligand and SMAD3
levels might be downregulated by Snail overexpression (the
adjusted p-values though were not signiﬁcant). We pro-
ceeded and analyzed several members of the TGFβ/activin
subfamily by a Taqman array (Fig. 3a); TGFB1, but not
TGFB2 or TGFB3 expression, was strongly reduced in
GBMs expressing Snail. In addition, TGFβ receptors
TGFBR2 and TGFBR3 were strongly reduced, whereas
TGFBR1 was upregulated; INHA, encoding one of the
activin subunits, and the activin extracellular antagonist
FST were dramatically upregulated as well as the growth
and differentiation factors GDF9 and GDF15 (Fig. 3a).
Furthermore, the Taqman array included 19 probes for
genes not related to the TGFβ family, whose expression did
not exhibit signiﬁcant changes (Supplementary Figure
S6B). TGFB1-3 quantitative reverse transcriptase PCR
corroborated the array results; SERPINE1/PAI1, an early
response gene of TGFβ1 signaling, was strongly under-
expressed, reﬂecting the downregulation of TGFB1 (Fig.
3b). In order to determine the protein level changes, we
interrogated the secretome of U2987MG-Snail cells by
analyzing secreted TGFβ1 levels (Fig. 3c) and protein
content of extracellular vesicles (EVs) by multiplex proxi-
mity extension assay (PEA) (Fig. 3d). GBMs expressing
Snail secreted lower SERPINE1 and LAP-TGFβ1 levels,
and their conditioned media contained less mature TGFβ1.
Concomitantly, total SMAD3, but not SMAD2 protein
levels, were decreased as shown by immunoblot and
quantitative immunoﬂuorescence analysis (Fig. 3e, f, Sup-
plementary Figure S6C).
Using MAPPER [25], we investigated whether Snail
could bind to the TGFB1 promoter. MAPPER predicted a
Snail-binding site in position −486 relative to the tran-
scription start site of the TGFB1 gene, next to a SMAD3-
binding site. Indeed, Snail did bind to the TGFB1 promoter,
as demonstrated by chromatin immunoprecipitation (ChIP;
Fig. 4a). We have previously published that Snail can
interact with SMAD3/4 during EMT [26]. In GSCs, endo-
genous SMAD2/3 interacted with Snail in response to
Fig. 2 Snail expression in GBMs induces BMP signaling, promoting
the astrocytic fate switch. U2987MG cells expressing pcDNA3-Snail
(clones F and G) or empty vector (clones A and B). a, c, d qRT-PCR
analysis of mRNA expression (n= 3, technical triplicate). b Immu-
noblot analysis for the indicated proteins and loading control Gapdh.
Representative experiment out of three. e TGFβ family-related gene
expression analyzed by Taqman array is graphed as fold-change of
expression in F-Snail versus A-pcDNA cells. A horizontal dotted line
indicates the onefold baseline (no change). f Human BMP4 protein
levels in conditioned media determined by ELISA (n= 2, technical
duplicate). g, h Cells were transiently transfected with siControl (−),
siSMAD1 and/or siSMAD5 (+) siRNAs; g qRT-PCR analysis of
mRNA expression (n= 2, technical triplicate), h quantiﬁcation of
nuclear pSmad1 staining. i, j Cells treated with or without Noggin
(0.25 µg/ml) for 48 h; i qRT-PCR analysis of mRNA expression (n=
2, technical triplicate), j quantiﬁcation of nuclear pSmad1 staining.
Results are expressed as mean± SD. Statistical comparison (one-way
Anova for a, c, d, e; two-way Anova for g–j) indicates signiﬁcant
differences at: *p< 0.05, **p< 0.01, ***p< 0.001
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TGFβ1 (Fig. 4b). Snail interacted with SMAD2 and
SMAD3 also in transfected human embryonic kidney cells
(Supplementary Figure S7A). Both N- and C-terminal Snail
domains associated with SMAD2/3 (Supplementary Figure
S7B, C). The N-terminal Mad-homology (MH) 1 domain of
SMAD contains the nuclear localization signal and binds to
DNA and many transcription factors; a middle Linker
region binds to ubiquitin ligases and regulates SMAD
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stability; the C-terminal MH2 domain transactivates gene
transcription, binds to type I receptors, and the very C-
terminal serine residues of R-SMADs are phosphorylated.
Snail interacted with deletion mutants lacking either
SMAD3 MH1 or MH2 domains (Fig. 4c), suggesting more
than one SMAD3 epitopes responsible for binding to Snail.
Snail also interacted with SMAD1/5 of the BMP pathway.
SMAD1 interacted through its MH1 and Linker domains
(Fig. 4d), whereas both N- and C-terminal Snail domains
associate with SMAD1/5 (Supplementary Figure S8).
Endogenous Snail interacted with endogenous SMAD1 and
SMAD4 in U2987MG and in Snail-expressing cells;
BMP7 stimulation enhanced complex formation (Fig. 4e, f).
Interestingly, silencing of Snail expression selectively
impairs TGFβ1 and BMP7 downstream effects. On one
hand, Snail silencing diminished the capacity of BMP7 to
induce GFAP expression and abrogated the ability of BMP7
to decrease the self-renewal of GSCs (Supplementary Fig-
ure S9A, B and ref. [13]). On the other hand, TGFβ1 is well
known to induce EMT [27]; in GBM, we uncovered that
TGFβ1 induces Snail and Slug expression, the latter in a
Snail-dependent manner (Supplementary Figure S9C).
However, the ability of TGFβ1 to promote GSC self-
renewal is not Snail dependent (Supplementary Figure
S9B). Thus Snail organizes extensive and selective cross-
talk with the TGFβ and BMP pathways.
Exogenous TGFβ1 rescues the stem-like features in
Snail-expressing GSCs
Snail transcriptionally represses the TGFB1 gene and
thereby suppresses the pro-stemness effects of this cytokine
in GBMs, and promotes efﬁcient GBM astrocytic fate
switch. We therefore investigated whether exogenous
TGFβ1 added to the GSC microenvironment might bypass
the cell-autonomous effects of Snail. By stimulating Snail-
expressing GSCs with recombinant TGFβ1, we observed
rescue of many phenotypic effects caused by Snail. TGFβ1
treatment restored sphere-forming capacity (Fig. 5a);
enhanced TGFB1, inhibitory SMAD6/7, and stem cell
marker NESTIN and LIF gene expression; and reduced ID4
and SPARCL1 levels (Fig. 5b, c). However, TGFβ1 did not
affect BMP4 or MEF/ELF4 (Fig. 5d); it even had a positive
effect on GFAP expression (Fig. 5c).
U2987MG-Snail cells upregulate BMP expression and
repress TGFβ1 signaling in order to promote astrocytic fate
and repress stemness. We observed that treating GSCs with
BMP7 and the TGFβ type I receptor inhibitor LY2157299/
galunisertib (L2) partially mimicked the effects of Snail
(Fig. 6); we chose BMP7 as it has been widely used to
induce GBM cell differentiation [14, 28]. This combina-
torial treatment strongly reduced sphere formation by
U2987MG cells (Fig. 6a), it induced ID4, and reduced
TGFB1 expression (Fig. 6b, c), almost to the levels mea-
sured in U2987MG-Snail cells; however, this combination
failed to repress stem cell marker, inhibitory SMAD6/7 or
BMP4 mRNA levels (Fig. 6b–d). As an inverse pharma-
cological control, we tested the GSC response to the BMP
receptor inhibitor DMH1 in combination with TGFβ1
ligand. In agreement with all previous results, DMH1
enhanced the response to TGFβ1 in terms of reducing
BMP4, ID4, and SPARCL1 expression; however, GFAP
expression could not be reduced, on the contrary, it was
further increased (Fig. 6b–d). Moreover, DMH1/TGFβ1 co-
treatment recovered the expression of endogenous TGFβ1
and rescued inhibitory SMAD6/7 and stem cell marker
NESTIN, LIF, and MEF expression in U2987MG-Snail
cells (Fig. 6b–d).
We investigated whether the in vitro effects of DMH1/
TGFβ1 or L2/BMP7 co-treatment were persistent in vivo.
We marked GBM cells with the green ﬂuorescent protein
(GFP), generating stably transfected U2987MG-GFP and
U2987MG-Snail-GFP clones; these were then treated with
the different factors for 72 h, prior to orthotopic injection in
the brains of newborn mice. Macroscopic tumors were
observed only in mice injected with U2987MG cells and
unexpectedly even in mice injected with cells pretreated
with BMP7 (Fig. 7a). U2987MG-Snail cells formed only
microscopic tumors, independently of the pretreatment
applied (Supplementary Figure S10, GFP staining). In
agreement with the incidence of macroscopic tumors,
U2987MG cells were more proliferative compared to
U2987MG-Snail cells in the tumor tissue (Fig. 7b, c,
Ki67 staining) and TGFβ1 inhibition (L2) reduced pro-
liferation, whereas BMP7 pretreatment did not; it even
slightly enhanced Ki67 staining in U2987MG parental cells.
Pretreatment with TGFβ1 or BMP receptor inhibitor
(DMH1) separately promoted U2987MG-Snail tumor cell
proliferation (Fig. 7b, c). The stem cell marker Nestin was
expressed in vivo at considerably lower levels in
U2987MG-Snail cells compared to U2987MG tumors as
Fig. 3 Snail suppresses TGFβ1 signaling. TGFβ family analysis in
U2987MG cells expressing pcDNA3-Snail (clones F and G) or the
empty vector (clones A and B). a TGFβ family-related gene expression
analyzed by Taqman array is graphed as fold-change of expression in
F-Snail versus A-pcDNA cells. A horizontal dotted line indicates the
onefold baseline (no change). b qRT-PCR analysis of mRNA
expression (n= 3, technical triplicate). c Human TGFβ1 protein levels
in conditioned media determined by ELISA (n= 2, technical dupli-
cate). d Protein expression analysis of secreted EVs by multiplex PEA
graphed as fold-change in F-Snail versus A-pcDNA cells. A horizontal
dotted line indicates onefold baseline (no change). e Immunoblot
analysis of the indicated proteins and Gapdh (representative experi-
ment). f Immunoﬂuorescence staining of SMAD3 (left) and quantiﬁ-
cation of nuclear SMAD3 staining (right). Results expressed as mean
± SD. Statistical comparison (one-way Anova) indicates signiﬁcant
differences at: *p< 0.05, ***p< 0.001
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expected by the expression proﬁle in vitro; TGFβ1 (L2) and
BMP (DMH1) receptor inhibitors enhanced Nestin expres-
sion in vivo, as they did in vitro (Fig. 7b, c, Nestin staining).
ID4, which marks BMP signaling activity, was expressed at
the same level in both U2987MG and U2987MG-Snail
tumors; BMP7 pretreatment, as expected, enhanced ID4
expression (Supplementary Figure S11). We monitored
phospho-SMAD2 and PAI1/SERPINE1 in order to assess
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TGFβ signaling activity in these tumors (Fig. 7b, c, Sup-
plementary Figure S11). In U2987MG-Snail cells, both
proteins gave weaker signals, and these signals were
enhanced after TGFβ or DMH1 inhibitor pretreatment, as
expected. These results show that Snail provides dual and
opposite regulation of BMP and TGFβ pathways, in order to
favor astrocytic fate and repress stemness (Supplementary
Figure S12). By regulating TGFβ family ligand expression,
Snail can suppress GBM tumorigenesis.
Discussion
Snail is involved in the progression of epithelial cancers but
is less studied in brain tumors. In epithelial tumors, it is well
established that expression of Snail correlates with EMT,
invasion, gain of cancer stem cell properties, and radio- and
chemo-resistance [17]. Snail-induced EMT also contributes
to tissue ﬁbrosis [17, 29]. In glioma, Snail promotes cell
migration [18, 19], as GBMs expressing high Snail are more
invasive compared to GBMs expressing low Snail levels
[13]. However, mice in which Snail-expressing cells had
been injected intracranially showed longer survival and
reduced efﬁciency of tumor formation [13]. These results
indicate that Snail promotes invasion and at the same time
limits GBM growth. We have now elucidated a novel
mechanism by which Snail exerts tumor-suppressor effects
in GBM and which explain how Snail can lead to reduced
tumor burden. Snail enhances BMP signaling (Figs. 1 and
2), which in turn primes an astrocytic fate switch, in
agreement with the differentiation potential of BMPs in
GBMs [11–14]. Blocking the BMP pathway using a BMP
type I receptor kinase small molecule inhibitor (DMH1),
knockdown of endogenous BMP receptors or SMAD1/5
and extracellular ligand trapping using a physiological BMP
antagonist (Noggin) abrogated the capacity of Snail to
promote astrocytic fate (Fig. 2; Supplementary Figure S4,
5). In contrast, endogenous activation of BMP signaling did
not contribute to the repression of stem cell markers by
Snail in the GSCs. This ﬁnding distinguishes differentiation
mechanisms mediated by Snail from mechanisms control-
ling stemness in GSCs.
A key factor that links Snail to suppression of GSC
stemness is TGFβ1 itself (Fig. 3). Snail represses the
TGFB1 gene, a well-known tumor promoter in GBM, which
enhances GSC proliferation and self-renewal in addition to
promoting intratumoral angiogenesis [8, 10, 30]. Thus,
Snail promotes BMP signaling and subsequent cell differ-
entiation, and by suppressing TGFβ1 and its downstream
signaling it also suppresses the survival and self-renewal of
GSCs. Accordingly, and in agreement with previous reports
[8, 10, 30], inhibiting TGFβ1 signaling reduces GBM pro-
liferation in vivo (Fig. 7). In this GBM model, BMP7
pretreatment was not sufﬁcient to suppress tumor develop-
ment, possibly due to the dose and length of the treatment
applied (Fig. 7). This ﬁnding also underscores that BMPs
may not induce terminal differentiation of tumor cells but
rather promote a plastic switch in cell fate [11]. Finally,
TGFβ1 pretreatment enhanced tumor cell proliferation,
stemness, and sustained TGFβ signaling in vivo (Fig. 7),
conﬁrming its pro-tumorigenic action in glioblastoma [8–
10]. Moreover, blocking the BMP pathway in U2987MG-
Snail cells phenocopied TGFβ pretreatment in vivo (Fig. 7),
conﬁrming the importance of Snail-induced BMP signaling
to prime for an astrocytic fate and maintain tumor-
suppressor effects.
Mechanistically, our work places Snail as a direct reg-
ulator of TGFβ1 expression, as Snail binds to and represses
the TGFB1 promoter (Figs. 3 and 4). Snail can activate
TGFβ signaling in mammary and renal epithelial cells [29,
31]; however, direct binding of Snail to the TGFB1 pro-
moter was not shown previously. Moreover, we now show
that Snail, via its N- and C-terminal domains, interacts with
the BMP and TGFβ R-SMAD MH1-Linker domains (Fig.
4; Supplementary Figure S7, 8).
The antagonistic effects of BMP signaling against TGFβ
are well established in embryonic development and in
cancer [27]. It remains to be examined further whether
BMPs promote SMAD1/5 complexes with Snail to regulate
additional target genes, which are important for astrocytic
differentiation and suppression of GSC stemness.
Fig. 4 Snail forms complexes with SMADs. a Snail ChIP on the
TGFB1 promoter in U2987MG cells expressing pcDNA3-Snail (clone
F) or the empty vector (clone A) (n= 3, technical triplicate). Results
expressed as mean ± SD. Statistical comparison (Student’s t-test)
indicates signiﬁcant differences at: *p<0.05. Rabbit IgG control
immunoprecipitation is shown. b Immunoprecipitation of endogenous
SMAD2/3 followed by immunoblotting for Snail and SMAD2/3 in
U2987MG cells stimulated with vehicle (–) or with 5 ng/ml TGFβ1 for
2 h (+). Negative control immunoprecipitation using non-speciﬁc IgG
and endogenous total cell lysate (TCL) protein levels before immu-
noprecipitation are shown. c Pulldown assay of 293T cell extracts
expressing pcDNA3-HA-Snail, loaded on puriﬁed GST or deletion
mutants of GST-SMAD3, followed by GST and HA immunoblotting.
Stars show speciﬁc SMAD3 constructs and input shows HA-Snail
levels prior to pulldown. d Pulldown assay of U2987MG cell extracts
expressing pcDNA3-Snail (clone F) or empty vector (clone A), loaded
on puriﬁed GST or deletion mutants of GST-SMAD1, followed by
GST and Snail immunoblotting. Arrows show each SMAD1 construct.
TCL shows endogenous protein levels before pulldown. e U2987MG
cells expressing pcDNA3-Snail (clone F) or empty vector (clone A)
stimulated with vehicle (–) or 30 ng/ml BMP7 for 2 h (+); (left) Snail
immunoprecipitation followed by Snail, SMAD1, and SMAD4
immunoblotting, (right) SMAD1 immunoprecipitation followed by
Snail, SMAD1, and SMAD4 immunoblotting. TCL shows endogen-
ous protein levels before immunoprecipitation. f U2987MG cells sti-
mulated with vehicle (−BMP7) or 30 ng/ml BMP7 for 2 h.
Immunoprecipitation of Snail (left), SMAD1 (middle), and SMAD4
(right) followed by Snail, SMAD1, and SMAD4 immunoblotting.
Negative control immunoprecipitation using non-speciﬁc IgG is
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Fig. 5 TGFβ1 restores stem-like growth in GSCs expressing Snail. a
ELDA of U2987MG cells (A-pcDNA and F-Snail) plated in
decreasing numbers (200–1 (cell/s)/well) in the presence or absence of
5 ng/ml TGFβ1 for 10 days (n= 2, technical octaplicate). Steeper
slopes indicate higher frequencies of colony-forming cells. A table
indicates average stem cell frequency for each group. b–d qRT-PCR
analysis of mRNA expression in cells stimulated with or without 5 ng/
ml TGFβ1 for 72 h (n= 3, technical triplicate). Results are expressed
as mean± SD. Statistical comparison (two-way Anova) indicates
signiﬁcant differences at: *p< 0.05, **p< 0.01, ***p< 0.001
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Fig. 6 BMP7 and TGFβ inhibitor co-treatment partially phenocopies
Snail function in GSCs. a ELDA of U2987MG cells (A-pcDNA and F-
Snail) plated in decreasing numbers (200–1 (cell/s)/well). A-pcDNA3
cells were treated with or without 30 ng/ml BMP7 in the presence or
absence of TGFβ inhibitor LY2157299 (L2, 2 µM). F-Snail cells were
treated with or without 5 ng/ml TGFβ1 in the presence or absence of
DMH1 (0.5 µM). Spheres were counted on day 10 (n= 2, technical
octaplicate); steeper slopes indicate higher frequencies of colony-
forming cells. The table indicates average stem cell frequency for each
group. b–d qRT-PCR analysis of mRNA expression in A-pcDNA cells
treated with BMP7 (30 ng/ml) and TGFβ inhibitor (L2, 2 µM) and in F
cells treated with TGFβ1 (5 ng/ml) and BMP inhibitor (DMH1, 0.5
µM) for 72 h (n= 2, technical triplicate). Results are expressed as
mean± SD. Statistical comparison (one-way Anova) indicates sig-
niﬁcant differences at: *p< 0.05, **p< 0.01, ***p< 0.001
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Fig. 7 Snail suppresses GBM in vivo. a Tumor formation in ortho-
topically xenografted immunodeﬁcient mice. b Immunohistochemistry
of GFP, Ki67, Nestin, and phospho-SMAD2. c Immunohistochemistry
quantiﬁcation: (left) % Ki67-positive nuclei expressed as a percentage
of tumor area; (center and right) reciprocal intensity of Nestin and
phosho-SMAD2. Data show mean± SD of 9–20 ﬁelds of 3 mice.
Statistical comparison (one-way Anova) indicates signiﬁcant differ-
ences at: *p< 0.05, **p< 0.01, ***p< 0.001
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Repression of TGFB1 by Snail is a key event that controls
GBM stemness; TGFβ1 alone or in combination with the
BMP type I receptor inhibitor, DMH1, helped GSCs
recover their self-renewal capacity and the expression of
speciﬁc stemness genes, such as NESTIN and LIF (Figs. 5
and 6). Combining exogenous TGFβ1 with DMH1 also
rescued inhibitory SMAD6/7 expression and blocked BMP4,
ID4, and astrocytic marker SPARCL1 expression (Fig. 6).
Interestingly, the combination of exogenous TGFβ1 with
DMH1 did not block GFAP expression (Fig. 6) as GFAP
can be induced by TGFβ1 in astrocytes during wound repair
mechanisms in the central nervous system [32, 33]. Alto-
gether, our data show that Snail limits the tumorigenic
potential of GBM by blocking GSC self-renewal and pro-
moting a fate switch toward the astrocytic lineage by con-
trolling in opposite ways different arms of the TGFβ family,
inducing the BMP arm, and repressing the TGFβ1 arm
(Supplementary Figure S12). This mechanism underscores
the importance of sequential and interdependent loops of
signaling by distinct TGFβ family members, a phenomenon
of widespread importance in cancer progression [27], which
is now shown to partake the key transcriptional regulator
Snail.
Materials and methods
Reagents
The mammalian expression constructs pcDNA3, pEGFP-
N1, and pcDNA3-Flag-tagged SMAD2/3/4 have been
described [34]. The pcDNA3-Flag-SMAD1/5 vectors were
kindly provided by K. Miyazono and T. Imamura (Tokyo
University and Ehime University, Japan, respectively) [35].
pGEX vectors encoding GST-SMAD1 and its deletion
mutants have been described [36]. The human Snail domain
plasmids were provided by A. García de Herreros (IMIM,
Barcelona, Spain) [37]. The silencing vectors pSuperior-
Neo-GFP (pSGN/shControl) and shSnail or pcDNA3-Snail
are described [34].
Cell culture and transfection
Human embryonic kidney 293T cells and GBM cells
U2987MG (previously described [38]) were cultured in
Dulbecco’s modiﬁed Eagle’s medium or Minimum Essential
Medium (MEM), respectively, supplemented with 10%
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml
penicillin, and 100 μg/ml streptomycin. Both cell lines
scored negatively for mycoplasma infection; the 293T cells
were authenticated by Short Tandem Repeat proﬁling.
U2987MG cells expressing pcDNA3, pcDNA3-Snail,
pSGN, or shSnail have been described [13]. Prior to
orthotopic brain injection, cells were further transfected
stably with the pEGFP-N1 plasmid using the FUGENE-HD
(Promega) protocol, generating U2987MG-GFP and
U2987MG-Snail-GFP clones, respectively.
GBM cells in MEM plus 10% FBS or stem cell media
(see extreme limiting dilution assay (ELDA) protocol) were
treated with TGFβ1 (5 ng/ml, Peprotech), BMP7 (30 ng/ml,
a gift from K. Sampath, Sanoﬁ-Genzyme Research Center,
Framingham, USA), Noggin (0.25 µg/ml, R&D Systems),
TGFβ type I receptor kinase inhibitor LY2157299 (L2, 2.5
µM, Sigma-Aldrich), and BMP type I receptor kinase
inhibitor DMH1 (500 nM, synthesized by the Ludwig
Cancer Research Ltd). Dimethyl sulfoxide was the vehicle
for the chemical inhibitors and 1 mM HCl/0.1% bovine
serum albumin for the growth factors.
siRNA transfection
Cells were transfected at 80% conﬂuence using a mixture of
DharmaFECT 1 and siRNA (20 nM) twice on 2 consecutive
days, according to the manufacturer (Dharmacon/GE
Healthcare). The human-speciﬁc siRNA oligonucleotides
were: ON-TARGETplus-SMARTpool-siCONTROL (D-
001810-10); ON-TARGETplus-SMARTpool-SMAD1 (L-
012723); ON-TARGETplus-SMARTpool-SMAD5 (L-
015791); ON-TARGETplus-SMARTpool-ACVR1 (L-
004924); ON-TARGETplus-SMARTpool-BMPR1B (L-
004934), and ON-TARGETplus-SMARTpool-SNAI1 (L-
010847).
RNA extraction and expression analysis
Cellular RNA was puriﬁed with the Nucleospin RNA Kit
(Macherey-Nagel) or Qiagen RNeasy Mini Kit (Qiagen);
gene expression was analyzed by real-time PCR as descri-
bed [39] with speciﬁc primers (Supplementary Table I).
TaqMan® Array Human TGFB Pathway (ThermoFisher
Scientiﬁc) analysis followed the manufacturer’s instructions
on the ABI 7900 HT instrument (Applied Biosystems,
California, USA).
The Affymetrix Genechip system U133 plus 2.0 and the
GeneChip 3’IVT Express protocol were used. Microarray
hybridization, scanning, and data normalization was per-
formed by the Uppsala University Array Platform according
to standard procedures (http://www.medsci.uu.se/klinfarm/a
rrayplatform/). Two independent samples for each cell clone
were analyzed, and the replicate is denoted as “bis”. To
identify genes that were signiﬁcantly regulated by Snail, we
compared U2987MG-Snail to U2987MG-mock cells and
ﬁltered gene expression based on an adjusted p< 0.01 using
geWorkbench [40]. The U2987MG expression proﬁles have
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been deposited to Array Express https://www.ebi.ac.uk/arra
yexpress/ with accession number E-MTAB-6151.
Immunoblotting and coimmunoprecipitation
Total proteins from transfected 293T or stimulated
U2987MG cells were extracted in 0.5 % Triton X-100, 0.5
% sodium deoxycolate, 20 mM Tris pH 7.4, 150 mM NaCl,
10 mM EDTA and complete protease inhibitor cocktail
(Roche) during 30 min on ice and centrifuged at 13,000 r.p.
m. for 10 min at 4 °C to remove insoluble debris. Proteins
were analyzed by sodium dodecyl sulfate (SDS) poly-
acrylamide gel electrophoresis (PAGE) or immunoprecipi-
tated with anti-Flag (1 µg), anti-SMAD1 (1 µg), anti-
SMAD4 (1 µg), anti-SMAD2/3 (2 µg), or anti-Snail (3 µg)
antibodies, and after four washes with lysis buffer, immu-
nocomplexes were resolved by SDS-PAGE and detected by
immunoblotting. The antibodies used were: rabbit-anti-
Nestin (Millipore, MAB5326), rabbit-anti-phospho-
SMAD2 (home-made) [34], rabbit-anti-SMAD3 (9523),
rabbit-anti-phospho-SMAD1/5 (9511), rabbit-anti-SMAD5
(9517), and rabbit-anti-Snail (C15D3) (Cell Signaling);
mouse-anti-SMAD1 (ab53745, Abcam); rabbit-anti-GFAP
(sc-6171), mouse-anti-SMAD4 (sc-7966), and mouse-anti-
GST (sc-138) (Santa Cruz Inc.); mouse-anti-SMAD2
(EB05147, Everest Biotech); mouse-anti-SMAD2/3
(610843, BD Biosciences); mouse-anti-HA (11666606001,
Roche); rabbit-anti-GFP (A111222, Invitrogen); and
mouse-anti-Flag M5 (F4042, Sigma). Mouse-anti-GAPDH
(AM4300, Ambion) was used as loading control in immu-
noblot analyses.
Chromatin immunoprecipitation
U2987MG (107) cells were crosslinked with 1% for-
maldehyde, neutralized with 0.125M glycine, washed with
ice-cold phosphate-buffered saline (PBS), and resuspended
in 50 mM Tris-HCl, pH 8.1, 1% SDS, 10 mM EDTA, and
complete protease inhibitors. ChIP assay was as described
previously [39]. The primers for the human TGFB1 pro-
moter were forward: GGGTGTTGAGTGACAGGAGG and
reverse: GAGGGTCTGTCAACATGGGG.
GST pulldown
GST-pulldown assays were as described previously [36].
Interaction assays of GST-SMAD1 with endogenous
U2987MG Snail used cell extracts prepared as in immu-
noblot with additional 1 mM NaOVO3. Extract aliquots
corresponding to ~107 cells were incubated with
glutathione-sepharose beads carrying 2.5 μg of GST-SMAD
fusions overnight at 4 °C. Bound proteins washed with lysis
buffer were resolved by 8% SDS-PAGE.
Immunoﬂuorescence microscopy
Immunoﬂuorescence protocol has been described pre-
viously [13]. The pSMAD1/5, SMAD2, pSMAD2, and
SMAD3 antibodies used were as described under immu-
noblotting. Random (5–10) pictures were taken with a
Nikon Eclipse 90i microscope (20× objective) at the same
exposure time for each protein. ImageJ64 10.2 software
(National Institutes of Health, Bethesda, MD, USA) was
used to quantify pixels in the nuclear area.
Extreme limiting dilution assay
ELDA was carried out as described [41]. U2987MG cells
were grown in 96-well plates in decreasing numbers (200–1
(cell/s)/well) in 200 μl of serum-free MEM supplemented
with 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml
streptomycin, 25 ng/ml epidermal growth factor, 25 ng/ml
basic ﬁbroblast growth factor, and B27 complement. On
day 10, the number of wells containing spheres for each cell
plating density was recorded and plotted using the online
ELDA analysis program (http://bioinf.wehi.edu.au/softwa
re/elda), which estimates a stem cell frequency for each
condition [41]. The data are plotted as log fraction of wells
without spheres as a function of the plated cell number.
EV proﬁle analysis
Cells were extensively washed with PBS and incubated for
several hours in serum-free medium to eliminate vesicles
stemming from serum. The wash step was repeated before
adding fresh serum-free medium and incubating for 48 h,
when media was sequentially centrifuged at 3000× g for 5
min to pellet cells and at 10,000× g for 10 min to remove
cell debris. Supernatants were ﬁltered (0.45 μm PES ﬁlter,
VWR) and pelleted at 100,000× g for 2 h at 4 °C. EVs were
resuspended in PBS containing protease inhibitors (Roche)
and lysed in (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
EDTA, pH 8, 1% Triton X-100, and 0.1% sodium deox-
ycholate) and protein concentration was measured by the
Dot-it-Spot-it Kit (http://dot-it-spot-it.com) according to the
manufacturer’s protocol. Speciﬁc proteins were analyzed by
multiplex PEA that is a 96-plex immunoassay for protein
detection in 1 µl of sample as described previously [42].
Normalized protein expression (log2-scale) was calculated
as described previously [43].
Enzyme-linked immunosorbent assay (ELISA)
U2987MG conditioned media were concentrated 50×
through Amicon Ultra-15 centrifugal ﬁlters (Millipore) at
3000× g for 15 min at 4 °C. Secreted BMP4 and TGFβ1
were measured using the human BMP4-ELISA Kit and the
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human TGFβ1-Duoset ELISA Kit, respectively (R&D
Systems), according to the manufacturer’s instructions.
Animal experiments
Animal experiments were performed in accordance to the
regulations of Uppsala University and approved by the local
ethics committee. U2987MG-pcDNA3-GFP and U2987-
MG-Snail-GFP (105 cells in 2 µl PBS) were stereotactically
injected into neonatal NOD-SCID mice (P0–2, both genders
used) using a motorized stereotactic injector (Stoelting) at a
pulse rate of 1.4 µl/min. The stereotactic coordinates, mea-
sured from lambda, were: anterio-posterior 1.5 mm, meso-
lateral 0.7 mm, and dorso-ventral 1.5 mm. Mice were
euthanized upon signs of sickness or distress, otherwise, at
14 weeks postinjection in compliance with the ethical
guidelines. Mouse brains were ﬁxed in 4% formalin and
tumors were examined histologically. Animal numbers are
reported in the ﬁgures; gender was not considered as a
parameter neither did any randomization method.
Immunohistochemistry (IHC)
Parafﬁn embedding of formalin-ﬁxed samples, sectioning,
IHC, and slide scanning were performed by the Science for
Life Laboratory facilities at the Department of Immunology,
Genetics, and Pathology of Uppsala University, Sweden, as
described [44]. Primary antibodies diluted in UltraAb
Diluent (Thermo Fisher Scientiﬁc) were applied for 30 min
at room temperature. The antibodies used at the indicated
dilutions were: anti-GFP (Invitrogen A111222, 1:2000),
anti-Ki67 (Abcam Ab15580, 1:1000), anti-Nestin (Milli-
pore MAB5326, 1:100), anti-ID4 (Santa Cruz, sc-491,
1:100), anti-phospho-SMAD2 (Invitrogen 44-244 G,
1:200), and anti-PAI1 (Abcam, Ab66705 1:200). The slides
were incubated with secondary antibody (Abcam Ab6721;
Goat-Anti-Rabbit IgG H&L (horseradish peroxidase),
1:1000) for 30 min at room temperature and scanned using
the automated scanning system Aperio XT (Aperio Tech-
nologies). Chromogen intensity was quantiﬁed using the
reciprocal intensity (r) method [45], where: r= 255−y, 255
being the maximum pixel intensity of unstained area (as
measured by the standard intensity function in the Fiji
software) and y=mean intensity of the selected tumor area.
Reciprocal intensity was quantiﬁed from one to six ﬁelds of
three mice per group; the number of ﬁelds depended on the
tumor size, and all analyses were performed without any
blinding.
Statistical analysis
For each experimental technique, unless otherwise stated in
the methods or ﬁgure legends, individual experiments were
repeated three or more times; this allowed us to reach high
statistical signiﬁcance in all the reported assays. Data were
analyzed using Prism GraphPad v6.0. A two-tailed Stu-
dent's t-test was performed in two-group comparisons. One-
way analysis of variance (Anova), followed by Sidak’s
multiple comparison test, was performed in multiple group
comparisons. Two-way Anova was used when comparing
TGFβ1 treatment on two different cell populations
(pcDNA3 versus pcDNA3-Snail). The variances were
similar between the groups under comparison in all these
cases.
Acknowledgements We thank Bengt Westermark and Karin Forsberg-
Nilsson (Dep. Immunology, Genetics Pathology, Uppsala University)
for human GBM cells; Kuber Sampath (Sanoﬁ-Genzyme Research
Center, Framingham) for recombinant BMP7; Kohei Miyazono
(Tokyo University) and Takeshi Imamura (Ehime University) for
SMAD vectors; Antonio Garcia de Herreros (IMIM, Barcelona) for
Snail vectors; Per-Henrik Edqvist (Dep. Immunology, Genetics,
Pathology, Uppsala University) and SciLifeLab Tissue Proﬁling plat-
form for IHC analysis; and Hanna Göransson Kultima (Dep. Medical
Sciences, Uppsala University) and Bioinformatics Infrastructure for
Life Sciences, Uppsala University for assistance with microarray
analysis. We thank George Divolis and members of our group for
suggestions and discussions.
Funding This work was supported by: Ludwig Cancer Research;
Swedish Cancer Society (CAN 2012/438, CAN 2015/438 to ArM);
and Swedish Research Council (K2013-66X-14936-10-5 to ArM,
2015-02757 to C-HH). LC was supported by postdoctoral fellowships
from Lisa Erikssons minnesfond (2013) and Swedish Cancer Society
(CAN 2012/1186).
Author contributions Conception and design: LC, ArM. Data acqui-
sition: LC, KT, MSD, E-JT, GH, NPM, AnM, LW, YW, KS. Data
analysis and interpretation: LC, KT, MSD, MK-M, LU, C-HH, ArM.
Article drafting and critical revision for important intellectual content:
LC, C-HH, ArM. Final approval prior to publication: all authors.
Compliance with ethical standards
Conﬂict of interest The authors declare that they have no competing
interests.
Open Access This article is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0 International License,
which permits any non-commercial use, sharing, distribution and
reproduction in any medium or format, as long as you give appropriate
credit to the original author(s) and the source, and provide a link to the
Creative Commons license. You do not have permission under this
license to share adapted material derived from this article or parts of it.
The images or other third party material in this article are included in
the article’s Creative Commons license, unless indicated otherwise in a
credit line to the material. If material is not included in the article’s
Creative Commons license and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to
obtain permission directly from the copyright holder. To view a copy
of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Snail controls GBM stem cells via TGFβ pathways 2529
References
1. Yan K, Yang K, Rich JN. The evolving landscape of glioblastoma
stem cells. Curr Opin Neurol. 2013;26:701–7.
2. Bonavia R, Inda MM, Cavenee WK, Furnari FB. Heterogeneity
maintenance in glioblastoma: a social network. Cancer Res.
2011;71:4055–60.
3. Haar CP, Hebbar P, Wallace GC, Das A, Vandergrift WA, Smith
JA, et al. Drug resistance in glioblastoma: a mini review. Neu-
rochem Res. 2012;37:1192–200.
4. Chen J, Li Y, Yu T-SS, McKay RM, Burns DK, Kernie SG, et al.
A restricted cell population propagates glioblastoma growth after
chemotherapy. Nature. 2012;488:522–6.
5. Ming GL, Song H. Adult neurogenesis in the mammalian brain:
signiﬁcant answers and signiﬁcant questions. Neuron.
2011;70:687–702.
6. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu
TD, et al. Molecular subclasses of high-grade glioma predict
prognosis, delineate a pattern of disease progression, and resemble
stages in neurogenesis. Cancer Cell. 2006;9:157–73.
7. Sakaki-Yumoto M, Katsuno Y, Derynck R. TGF-β family sig-
naling in stem cells. Biochim Biophys Acta. 2013;1830:2280–96.
8. Bruna A, Darken RS, Rojo F, Ocaña A, Peñuelas S, Arias A, et al.
High TGFbeta-Smad activity confers poor prognosis in glioma
patients and promotes cell proliferation depending on the
methylation of the PDGF-B gene. Cancer Cell. 2007;11:147–60.
9. Peñuelas S, Anido J, Prieto-Sánchez RM, Folch G, Barba I,
Cuartas I, et al. TGF-beta increases glioma-initiating cell self-
renewal through the induction of LIF in human glioblastoma.
Cancer Cell. 2009;15:315–27.
10. Ikushima H, Todo T, Ino Y, Takahashi M, Saito N, Miyazawa K,
et al. Glioma-initiating cells retain their tumorigenicity through
integration of the sox axis and oct4 protein. J Biol Chem.
2011;286:41434–41.
11. Carén H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E,
Bartlett TE, et al. Glioblastoma stem cells respond to differ-
entiation cues but fail to undergo commitment and terminal Cell-
Cycle arrest. Stem Cell Rep. 2015;5:829–42.
12. Piccirillo SGM, Reynolds BA, Zanetti N, Lamorte G, Binda E,
Broggi G, et al. Bone morphogenetic proteins inhibit the
tumorigenic potential of human brain tumour-initiating cells.
Nature. 2006;444:761–5.
13. Savary K, Caglayan D, Caja L, Tzavlaki K, Bin Nayeem S,
Bergström T, et al. Snail depletes the tumorigenic potential of
glioblastoma. Oncogene. 2013;32:5409–20.
14. Tate CM, Pallini R, Ricci-Vitiani L, Dowless M, Shiyanova T,
D’Alessandris GQ, et al. A BMP7 variant inhibits the tumorigenic
potential of glioblastoma stem-like cells. Cell Death Differ.
2012;19:1644–54.
15. Yan K, Wu Q, Yan DH, Lee CH, Rahim N, Tritschler I, et al.
Glioma cancer stem cells secrete Gremlin1 to promote their
maintenance within the tumor hierarchy. Genes Dev.
2014;28:1085–100.
16. Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE,
Estrem ST, et al. Clinical development of galunisertib
(LY2157299 monohydrate), a small molecule inhibitor of trans-
forming growth factor-beta signaling pathway. Drug Des Dev
Ther. 2015;9:4479–99.
17. Nieto MA. Epithelial plasticity: a common theme in embryonic
and cancer cells. Science. 2013;342:1234850.
18. Mahabir R, Tanino M, Elmansuri A, Wang L, Kimura T, Itoh T,
et al. Sustained elevation of Snail promotes glial-mesenchymal
transition after irradiation in malignant glioma. Neuro Oncol.
2014;16:671–85.
19. Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD.
SNAI2/Slug promotes growth and invasion in human gliomas.
BMC Cancer. 2010;10:301.
20. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Chris-
topherson KS, et al. A transcriptome database for astrocytes,
neurons, and oligodendrocytes: a new resource for understanding
brain development and function. J Neurosci. 2008;28:264–78.
21. Kobayashi A, Okuda H, Xing F, Pandey PR, Watabe M, Hirota S,
et al. Bone morphogenetic protein 7 in dormancy and metastasis
of prostate cancer stem-like cells in bone. J Exp Med.
2011;208:2641–55.
22. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci
STKE 2002;2002:pe40.
23. Whissell G, Montagni E, Martinelli P, Hernando-Momblona X,
Sevillano M, Jung P, et al. The transcription factor GATA6
enables self-renewal of colon adenoma stem cells by repressing
BMP gene expression. Nat Cell Biol. 2014;16:695–707.
24. Caja L, Bellomo C, Moustakas A. Transforming growth factor β
and bone morphogenetic protein actions in brain tumors. FEBS
Lett. 2015;589:1588–97.
25. Marinescu VD, Kohane IS, Riva A. The MAPPER database: a
multi-genome catalog of putative transcription factor binding
sites. Nucleic Acids Res. 2005;33:D91–7.
26. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J,
et al. A SNAIL1-SMAD3/4 transcriptional repressor complex
promotes TGF-beta mediated epithelial-mesenchymal transition.
Nat Cell Biol. 2009;11:943–50.
27. Caja L, Kahata K, Moustakas A. Context-dependent action of
transforming growth factor beta family members on normal and
cancer stem cells. Curr Pharm Des. 2012;18:4072–86.
28. González-Gómez P, Crecente-Campo J, Zahonero C, de la Fuente
M, Hernández-Laín A, Mira H, et al. Controlled release micro-
spheres loaded with BMP7 suppress primary tumors from human
glioblastoma. Oncotarget. 2015;6:10950–63.
29. Grande MT, Sánchez-Laorden B, López-Blau C, De Frutos CA,
Boutet A, Arévalo M, et al. Snail1-induced partial epithelial-to-
mesenchymal transition drives renal ﬁbrosis in mice and can be
targeted to reverse established disease. Nat Med. 2015;21:989–97.
30. Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty
JH. Glioblastoma angiogenesis and tumor cell invasiveness are
differentially regulated by β8 integrin. Cancer Res.
2011;71:6371–81.
31. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. The
transcription factors Snail and Slug activate the transforming
growth factor-beta signaling pathway in breast cancer. PLoS
ONE. 2011;6:e26514.
32. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS. TGFβ
signaling in the brain increases with aging and signals to astro-
cytes and innate immune cells in the weeks after stroke. J Neu-
roinﬂamm. 2010;7:62.
33. Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK,
Degen JL, et al. Fibrinogen triggers astrocyte scar formation by
promoting the availability of active TGF-beta after vascular
damage. J Neurosci. 2010;30:5843–54.
34. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A.
HMGA2 and Smads co-regulate SNAIL1 expression during
induction of epithelial-to-mesenchymal transition. J Biol Chem.
2008;283:33437–46.
35. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Ima-
mura T, et al. Smurf1 interacts with transforming growth factor-
beta type I receptor through Smad7 and induces receptor degra-
dation. J Biol Chem. 2001;276:12477–80.
36. Watanabe Y, Papoutsoglou P, Maturi V, Tsubakihara Y, Hottiger
MO, Heldin C-H, et al. Regulation of bone morphogenetic protein
signaling by ADP-ribosylation. J Biol Chem. 2016;291:12706–23.
2530 L. Caja et al.
37. Villagrasa P, Díaz VM, Viñas-Castells R, Peiró S, Del Valle-Pérez
B, Dave N, et al. Akt2 interacts with Snail1 in the E-cadherin
promoter. Oncogene. 2012;31:4022–33.
38. Ferletta M, Caglayan D, Mokvist L, Jiang Y, Kastemar M, Uhr-
bom L, et al. Forced expression of Sox21 inhibits Sox2 and
induces apoptosis in human glioma cells. Int J Cancer.
2011;129:45–60.
39. Tan E-J, Kahata K, Idas O, Thuault S, Heldin C-H, Moustakas A.
The high mobility group A2 protein epigenetically silences the
Cdh1 gene during epithelial-to-mesenchymal transition. Nucleic
Acids Res. 2015;43:162–78.
40. Floratos A, Smith K, Ji Z, Watkinson J, Califano A. geWork-
bench: an open source platform for integrative genomics. Bioin-
formatics. 2010;26:1779–80.
41. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for
comparing depleted and enriched populations in stem cell and
other assays. J Immunol Methods. 2009;347:70–8.
42. Larssen P, Wik L, Czarnewski P, Eldh M, Löf L, Ronquist KG,
et al. Tracing cellular origin of human exosomes using multiplex
proximity extensionassays. Mol Cell Proteom. 2017;16:502–11.
43. Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen
SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay
exhibiting high sensitivity, speciﬁcity, and excellent scalability.
PLoS One. 2014;9:e95192.
44. Kampf C, Olsson I, Ryberg U, Sjöstedt E, Pontén F. Production of
tissue microarrays, immunohistochemistry staining and digitali-
zation within the human protein atlas. J Vis Exp. 2012:e3620.
45. Nguyen D, Zhou T, Shu J, Mao J Quantifying chromogen
intensity in immunohistochemistry via reciprocal intensity. Cancer
InCytes. 2013;2. https://doi.org/10.1038/protex.2013.097.
Snail controls GBM stem cells via TGFβ pathways 2531
